KLK3 and prostate carcinoma: For example, 2038 and 2340 intron retention events have been detected in breast cancer and lung carcinoma, respectively, while intron 4 of KLK3 (PSA) transcript was specifically retained in the majority of patients in a prostate cancer cohort [28,29,30,31].